- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01736774
Exercise and Manipulative Therapy for Older Persons With Headache
26 janvier 2016 mis à jour par: Sureeporn Uthaikhup, Chiang Mai University
A Randomized Controlled Trial of Exercise and Manipulative Therapy for Older Persons With Frequent Intermittent Headaches Associated With Neck Pain and Impairment
The presence of cervical musculoskeletal impairment is not specific to cervicogenic headache but other various frequent intermittent headache types (i.e.
migraine and tension-type headache) in the elderly population.
There has been no trial to date which has investigated the effectiveness of physiotherapy treatment specifically for older persons with various types of headache with associated neck pain and cervical musculoskeletal impairment.
Thus, the purpose of study investigate the efficacy of physiotherapy treatment for older persons who have headache concomitant with neck pain and musculoskeletal impairment
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Headache is a common health problem that affects quality of life in an older population and imposes substantial economic costs.
Headache changes with age.
Features of headache become less typical and neck pain is more frequently associated with headache in older persons.
We recently demonstrated that the presence of cervical musculoskeletal impairment is not specific to cervicogenic headache (headache caused by the neck).
Rather it was present in various frequent intermittent headache types in elders when compared to elders without headache.
Changes in headache characteristics with age play an important role not only in diagnosis but also in treatment choice.
Impairment in cervical musculoskeletal function found in older persons with headache has implications for headache management choices as the evidence indicates that physiotherapy management methods such as manual therapy and therapeutic exercise are an effective management approach for headache associated with the neck.
Physiotherapy treatment would be a safe therapeutic option and may have a beneficial effect for elders with headache who have neck pain and concomitant cervical musculoskeletal dysfunction.
This is particularly relevant as there are widespread concerns about medication overuse, adverse drug events and drug interactions in older persons.
The effective management of older persons with headache in particular of those with atypical features of headache remains a challenge.
Physiotherapy is indicated in those older persons diagnosed with cervicogenic headache but could also be adjunct treatment for those with cervical musculoskeletal signs who are suspected of having transitional headache.
At present, there has been no trial to date which has investigated the effectiveness of physiotherapy treatment specifically for older persons with various types of headache with associated neck pain and cervical musculoskeletal impairment.
A clinical trial of treatment of cervical musculoskeletal impairment in older persons with various headache types may help guide management of headache in attempts to lesson medication use and cost in this population.
Physiotherapy management may be a worthy treatment option particularly in older persons with headache who do not respond well to medication.
Type d'étude
Interventionnel
Inscription (Réel)
65
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Chiang Mai, Thaïlande
- Department of Physical Therapy, Faculty of Associated Medical Sciences
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
50 ans à 75 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Volunteers suffering from frequent intermittent headache (either migraine, tension-type headache or cervicogenic headache) at least one per month over a period of 3 months or longer
- Aged 50 years or older, female or male
- A score of ≥ 3/10 on visual analogue scale (VAS) of neck pain
- Evidence of cervical musculoskeletal impairment: restriction in active range of cervical motion in extension and rotation and join tenderness in at least one of the upper joint as detected by manual palpation
Exclusion Criteria:
- Headache diagnosed as following: temporal arteritis, trigeminal neuralgia, cluster headache, chronic paroxysmal hemicrania/hemicranias continua, temporomandibular joint dysfunction
- Other diagnosed disorders: cerebrovascular disease, Parkinson disease, cognitive disturbance
- Previous history of head or neck surgery
- Lack of willingness to receive either pragmatic treatment or usual care
- Physiotherapy or chiropractic treatment for headache in previous 6 months
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Usual care intervention
Primary care as required including medication
|
The usual care intervention will include appropriate primary care as required including medication
|
|
Expérimental: Physiotherapy treatment
Exercise and manipulative therapy
|
Exercise and manipulative therapy treatment for 10 weeks:The treatment intervention consists of two visits per week for the first four weeks (8 treatments) and one visit per week for the last six weeks (6 treatments)
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Headache frequency
Délai: Change from baseline in headache frequency at week 11 and 6 months after intervention
|
The number of headache frequency in the past week
|
Change from baseline in headache frequency at week 11 and 6 months after intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Headache intensity
Délai: Change from baseline in headache intensity at week 11 and 6 months after intervention
|
An average intensity in the past week will be rated on a 1-10 VAS
|
Change from baseline in headache intensity at week 11 and 6 months after intervention
|
|
Headache duration
Délai: Change from baseline in headache duration at week 11 and 6 months after intervention
|
The number of hours of headache in the past week
|
Change from baseline in headache duration at week 11 and 6 months after intervention
|
|
Neck pain intensity
Délai: Change from baseline in neck pain intensity at week 11 and 6 months after intervention
|
Intensity of neck pain will be measured using a 1-10 VAS
|
Change from baseline in neck pain intensity at week 11 and 6 months after intervention
|
|
Neck pain and disability
Délai: Change from baseline in neck pain and disability at week 11 and 6 months after intervention
|
Neck pain and disability will be measured using neck disability index (NDI-Thai version)
|
Change from baseline in neck pain and disability at week 11 and 6 months after intervention
|
|
Quality of life
Délai: Change from baseline in quality of life at week 11 and 6 months after intervention
|
The Quality of life will be measured using SF-36 (Thai version)
|
Change from baseline in quality of life at week 11 and 6 months after intervention
|
|
Medication intake
Délai: Change from baseline in medication intake at week 11 and 6 months after intervention
|
type and dose of all medications taken by subjects will be recorded one week at baseline and prior to follow-up points on a medication diary
|
Change from baseline in medication intake at week 11 and 6 months after intervention
|
|
Global assessment of treatment benefit
Délai: Changes from baseline in global assessment of treatment benefit at week 11 and 6 months after intervention
|
Patients perceived benefit of treatment will be measured on a scale from 0 (no benefit) to 10 (maximum benefit)
|
Changes from baseline in global assessment of treatment benefit at week 11 and 6 months after intervention
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: Sureeporn Uthaikhup, Ph.D., Department of Physical Therapy, Faculty of Associated Medical Sciences
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 décembre 2012
Achèvement primaire (Réel)
1 décembre 2014
Achèvement de l'étude (Réel)
1 juillet 2015
Dates d'inscription aux études
Première soumission
22 novembre 2012
Première soumission répondant aux critères de contrôle qualité
26 novembre 2012
Première publication (Estimation)
29 novembre 2012
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
28 janvier 2016
Dernière mise à jour soumise répondant aux critères de contrôle qualité
26 janvier 2016
Dernière vérification
1 janvier 2016
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- MRG5580145
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .